Earnings Call · Q3 FY2022·2023-02-06

Q3 22EPS -88.24%·Rev n/aQ2 22EPS -34.62%·Rev n/aQ1 22EPS -34.78%·Rev n/aQ4 21EPS +7.14%·Rev n/a⚠ consensus missing

PETMED EXPRESS INC PETS

Brian Prenoveau — Investor Relations

Matthew Hulett — Chief Executive Officer

Christine Chambers — Chief Financial Officer

−4.3%1d on move date−5.6% vs SPY3d−3.1%5d−1.9%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PETS calls or request research access.

More PETS calls Browse calls Request research access